Chrome Extension
WeChat Mini Program
Use on ChatGLM

Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT-P47 and Reference Tocilizumab: A Randomized, Double-Blind, Phase 1 Study

Journal of clinical pharmacology(2024)

Cited 0|Views3
Key words
biosimilar,CT-P47,immunogenicity,pharmacokinetics,safety,tocilizumab
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined